Status: Not yet recruiting
Sonazoid CEUS for Early HCC Surveillance
This study is a multicenter, prospective study. In this study, enrolled subjects are cirrhotic patients of any etiology. The US and Sonazoid CEUS monitoring strategy was performed for cirrhotic patients: US and AFP joint with Sonazoid CEUS every 4 to 6 months, and combined CECT/CEMRI every 12 months.
Participants needed: 556
Trial details
Age: 18-80Biological sex: AllType: InterventionalSponsor: Tianjin Third Central HospitalUpdated: May 15, 2026Locations: 1
Eligibility criteria
Cirrhotic patients diagnosed clinically or radiologically due to any etiology (p... [+3]
Patients with pathologic or enhanced imaging of established HCC who have not und... [+5]